Newsfeeds Archive - Page 2 of 7

1 minute read

eFFECTOR Therapeutics Announces $15M Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

January 25, 9:11 AM

eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR) (the "Company"), a leader in the development of selective translation regulator inhibitors ("STRIs") for the treatment of cancer, today announced that it has entered into a

EFTR

1 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights

January 24, 5:31 PM

Gainers Acutus Medical (NASDAQ:AFIB) shares rose 49.2% to $0.34 during Wednesday’s after-market session. The market value of their…

AFIB

3 minute read

Dow Tumbles Over 200 Points; US Trade Gap Narrows In November

By Avi Kapoor

January 9, 10:40 AM

U.S. stocks traded lower this morning, with the Dow Jones falling more than 200 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.63% to 37,445.51 while the NASDAQ fell 0.66% to 14,745.96. The S&P 500 also fell, dropping, 0.55% to 4,737.17.

BETS

2 minute read

eFFECTOR Therapeutics Announces 1-For-25 Reverse Stock Split, Will Become Effective At 12:01 A.M. Eastern Time, On January 12, 2024.

By Benzinga Newsdesk

January 9, 9:10 AM

eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR), a leader in the development of selective translation regulator inhibitors ("STRIs") for the treatment of cancer, today announced that its Board of Directors (the "Board") has

EFTR

1 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Pre-Market Session

By Benzinga Insights

January 9, 9:06 AM

Gainers Aura Biosciences (NASDAQ:AURA) stock moved upwards by 44.3% to $13.0 during Tuesday’s pre-market session. The company’s market…

APLM

2 minute read

Why LumiraDx Shares Are Trading Lower By Over 30%; Here Are 20 Stocks Moving Premarket

By Avi Kapoor

January 8, 9:20 AM

Shares of LumiraDx Limited (NASDAQ: LMDX) shares fell sharply in pre-market trading. LumiraDx announced its securities will be suspended from trading on Nasdaq at the open of business on Jan. 9th. LumiraDx shares dipped 30.5% to $0.0239 in pre-market trading.

AIMD

4 minute read

Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday’s Mid-Day Session

By Avi Kapoor

December 11, 2:12 PM

Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition.

AAGR

2 minute read

Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket

By Avi Kapoor

December 11, 8:59 AM

Shares of Green Giant Inc. (NASDAQ: GGE) fell sharply in pre-market trading after announcing a proposed public offering. Green Giant shares dipped 37.1% to $0.1599 in pre-market trading. Here are some other stocks moving in pre-market trading.

AAGR

1 minute read

eFFECTOR Therapeutics Discloses Updated Data From Mid-Stage Breast Cancer Study

By Vandana Singh

December 8, 12:43 PM

eFFECTOR Therapeutics Inc (NASDAQ: EFTR) announced new interim data from dose escalation and Phase 2 expansion cohorts of a Phase 1/2 study of zotatifin in patients with estrogen receptor positive (ER+)

EFTR

3 minute read

Why Edible Garden Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

November 13, 2:08 PM

Edible Garden AG Incorporated (NASDAQ: EDBL) shares fell on Monday following third-quarter results.

ACRS